Drugs / 5-Azacitadine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02178072 | Feb 2015 → Oct 2019 | head and neck squamous cell carcinoma | Yale University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-Azacitadine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02178072 ↗ |